NEW YORK, May 31, 2017 – Jefferies today announced that it will host its 2017 Healthcare Conference
June 6-9 in New York.
The conference will feature an extensive range of global public and private healthcare companies across the Biopharmaceuticals, Life Sciences, Healthcare Services, Healthcare IT and Medical Technology sectors.
This comprehensive gathering of key industry participants, including over 400 presenting companies and more than 2,500 institutional investors, will address significant trends and developments within the global Healthcare sector. The conference is comprised of company presentations, Q&A breakout sessions, workshops and thematic panels, providing an ideal forum for discussion on some of the most relevant and important issues facing the industry today.
The June 8 lunch keynote will be an interview of Michael R. Bloomberg by Brian Friedman, Chairman of the Executive Committee, Jefferies LLC & President, Leucadia National Corporation (NYSE: LUK).
Notable panel topics include:
Political Agenda: ACA, AHCA, and Tax Reform
Cutting Edge Therapies in Dermatology
Adoption of Emerging Genomic Tools for Oncology in Clinical Diagnostics
Medical Devices: The Hospital Perspective
The “New” FDA Under the Leadership of Scott Gottlieb
The Best of ASCO
Biopharma M&A: A View from Multi-National Pharma
Trends in Private Equity Investing
Trends in Venture Capital Investing
Jon Santemma, Global Head of Healthcare Investment Banking at Jefferies, commented, “As one of the two largest global conferences dedicated to the healthcare sector, Jefferies Healthcare Conference provides institutional investors and corporate management teams with a dynamic environment to identify new opportunities and themes across the broader healthcare sector. This conference confirms Jefferies’ commitment to this important sector and to creating valuable opportunities for our clients.”
As part of the firm’s commitment to the healthcare sector, Jefferies has over 100 healthcare-focused investment bankers in New York, San Francisco, London and Hong Kong. Additionally, Jefferies has 20 senior healthcare equity research analysts covering approximately 340 healthcare companies globally.
For further information about the Jefferies 2017 Healthcare Conference, including the agenda, attending companies and how to register, please contact your Jefferies representative or email firstname.lastname@example.org. You must be pre-registered to attend the conference.
Jefferies, the world's only independent full-service global investment banking firm focused on serving clients for over 50 years, is a leader in providing insight, expertise and execution to investors, companies and governments. Our firm provides a full range of investment banking, sales, trading, research and strategy across the spectrum of equities, fixed income and foreign exchange, as well as wealth management, in the Americas, Europe and Asia. Jefferies Group LLC is a wholly-owned subsidiary of Leucadia National Corporation (NYSE: LUK), a diversified holding company.
For media inquiries, please contact: